Pulm Circ. 2014 Sep;4(3):370-7. doi: 10.1086/676747.
Congenital heart disease and pulmonary arterial hypertension in South America (2013 Grover Conference series).
Pulmonary circulation
Antonio Augusto Lopes, Patricia C Flores, Gabriel F Diaz, Sonia M F Mesquita
Affiliations
Affiliations
- Heart Institute (InCor), University of São Paulo School of Medicine, São Paulo, Brazil.
- Hospital Patronato Municipal San Jose Sur, Quito, Ecuador.
- National University, Bogota, Colombia.
PMID: 25621150
PMCID: PMC4278596 DOI: 10.1086/676747
Abstract
South America is a territory of 17,819,100 km(2), where ∼388 million people live in 13 countries. In the region, access to medical assistance (e.g., for treatment of cardiovascular disorders) is relatively easy in metropolitan areas but difficult in remote places such as the Andes and the Amazon. Altitudes up to ∼6,700 m influence the prevalence of congenital heart disease (CHD) and pulmonary arterial hypertension (PAH). In tertiary centers, CHD is now treated earlier in life but remains an important etiology of PAH. In adolescents and adults with PAH assisted at institutions devoted to treatment of cardiovascular disorders, the relative frequency of PAH-CHD (∼50%-60%) is even higher than that of idiopathic PAH. In one big tertiary center in São Paulo, Brazil, the prevalence of advanced PAH in children and adults with CHD is 1.2% and 4.2%, respectively. In young patients with cardiac septal defects (aged up to 2 years), pulmonary vascular abnormalities are a matter of concern in the decision about operability in 4.9% of cases. Access to specific PAH drugs is not uniform in South America, being unrealistic in remote places. In big cities, there are real possibilities for management of complex CHD, neonatal disorders, and even cardiac transplantation. Research activities have been implemented at clinical, translational, and basic levels. However, because of social and economic inequalities and political issues, access to best standards of medical care remains a problem in the region as a whole.
Keywords: congenital heart disease; pediatric cardiac surgery; pulmonary hypertension; survival; von Willebrand factor
References
- Pulm Circ. 2012 Jul;2(3):273-4 - PubMed
- J Thorac Cardiovasc Surg. 1984 Jun;87(6):876-86 - PubMed
- Am Heart J. 2000 Apr;139(4):618-23 - PubMed
- Circulation. 2001 Apr 24;103(16):2078-83 - PubMed
- Heart. 2007 Jun;93(6):682-7 - PubMed
- Am J Med. 1998 Jul;105(1):21-6 - PubMed
- Pediatrics. 1964 Oct;34:568-82 - PubMed
- Eur Respir J. 1995 Apr;8(4):530-6 - PubMed
- Circulation. 1963 Nov;28:915-25 - PubMed
- Cardiovasc Res. 2006 Oct 1;72(1):41-50 - PubMed
- Thorax. 1981 Aug;36(8):599-604 - PubMed
- Thorax. 1989 Dec;44(12):981-3 - PubMed
- Chest. 2005 Oct;128(4):2355-62 - PubMed
- J Thorac Cardiovasc Surg. 2001 Feb;121(2):279-89 - PubMed
- Am J Cardiol. 2000 Nov 15;86(10):1111-6 - PubMed
- Chest. 2010 Jun;137(6 Suppl):78S-84S - PubMed
- Braz J Med Biol Res. 2011 Dec;44(12):1269-75 - PubMed
- High Alt Med Biol. 2006 Summer;7(2):168-79 - PubMed
- Am J Cardiol. 1963 Feb;11:143-9 - PubMed
- Thromb Haemost. 2000 May;83(5):683-7 - PubMed
- Chin Med J (Engl). 2008 Dec 20;121(24):2469-72 - PubMed
- J Am Coll Cardiol. 1988 Jul;12(1):224-8 - PubMed
- High Alt Med Biol. 2005 Summer;6(2):147-57 - PubMed
- Circulation. 2007 Mar 6;115(9):1132-46 - PubMed
- Chest. 1993 Nov;104(5):1455-60 - PubMed
- High Alt Med Biol. 2008 Fall;9(3):199-207 - PubMed
- Respir Physiol Neurobiol. 2007 Sep 30;158(2-3):190-203 - PubMed
Publication Types